Sirtris Pharmaceuticals™ (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. It plans to trade on the Nasdaq under ticker symbol SIRT, with JPMorgan serving as lead underwriter. Compare performance of key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial and Treasury. Find the latest stock market trends and activity today. Describes a set of key strategic decisions facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. GVKEY for each Company remains the same through all the years. This is the Cambridge home of two-year-old Sirtris Pharmaceuticals. Case: Sirtris Pharmaceuticals: Living healthier, longer The objective of the analysis is to respond to the case questions in a logical and structured manner. Sirtris has raised $67 million in VC funding since its 2002 inception (plus $15m in […] Dear David: Thank you for agreeing to become a consultant to Sirtris Pharmaceuticals, Inc. (the "Company"). Ticker ZEN - was ticker for Zeneca before it became AstraZeneca. Any idea when, The news with SIRT just keeps getting better, And, especially with the baby boomer generation reaching, Especially since many of the current drugs used, With Type 2 Diabetes and Obesity having reached, Positive trial results picked up all over the, "SIRT1 transgenic mice show phenotypes resembling calorie restriction.Bordone, SIRT on NIGHTLINE,RIGHT NOW..............I need a drink of. They can ... 2008 SIRT 82968A105 B1XN4P5 US82968A1051 SIRTRIS PHARMACEUTICALS, INC. UNITED STATES 2834. Sirtris Pharma: SRT501 Data Is From Pre-Clinical Models. If you are looking for general information or articles related to a term or company, use this box: Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases. It had originally filed to sell 5 million shares at between $9 and $11 per share. 2021 Catabasis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. Sirtris Pharmaceuticals Inc Sirtris Pharmaceuticals, Inc. operates as a biopharmaceutical company. http://phx.corporate-ir.net/phoenix.zhtml?c=185399&p=irol-news&nyo=0. Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, General contact email for the organization, Auto-generated name of transaction (e.g. East Coast Companies that Exited (Top 10K), New England Health Care Acquired Companies. Sirtris Pharmaceuticals acquired by GlaxoSmithKline, Name of the organization that made the acquisition, Total amount raised across all funding rounds, Total number of current team members an organization has on Crunchbase, Total number of investment firms and individual investors, Descriptive keyword for an Organization (e.g. 11/3/2010. 4/22/2010. Energesis Pharmaceuticals, Co-Founded by Sirtris Pharmaceuticals Veteran, Seeks to Tap Power of "Good Fat" in Fighting Obesity and Diabetes. SIRTRIS PHARMACEUTICALS, INC. April 15, 2005. Common lookup errors can help. Sirtris Pharmaceuticals Inc. said it would sell 5 million shares in its initial public offering at between $9 and $11 apiece. Sirtris Pharmaceuticals Inc. has been sold for $720 million to international pharmaceutical company GlaxoSmithKline (NYSE: GSK), just four years after the biotechnology startup launched. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Sirtris can help keep you healthy in your golden years. InvestorsHub.com, Inc. Currently, assigned to ZenDesk Tickers can change. The Company discovers and develops proprietary, orally available, small molecule drugs. Company name, ISIN, SEDOL, SIC are header Its proposed ticker … Visit a quote page and your recently viewed tickers will be displayed here. Sirtris Pharmaceuticals is registered under the ticker NASDAQ:SIRT. Sirtris’ employees and investors alike were satisfied with the $720 million cash acquisition of the Company by GSK priced at $22.50 per share – an 84% premium to the $12.23 share price on the day preceding the tender offer announcement, and a 125% premium to Sirtris Pharmaceuticals’ May 2007 initial public offering price of $10 per share. Sirtris scientists believe a group of enzymes, called sirtuins, are capable of fighting age-related diseases by playing a key role in vital cell processes like DNA repair and programmed cell death. Search Tickers. Its stated goal is to develop medicines that have the same health-boosting effects in people that resveratrol had on mice. Should the company establish a proposed alliance with a pharmaceutical firm? Active, Closed, Last funding round type (e.g. Visit a quote page and your recently viewed tickers will be displayed here. Sirtris has already started a larger drug study. Sirtris Pharmaceuticals ' first drug is a treatment for diabetes. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Sirtris Pharmaceuticals is funded by 10 investors. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: X: 10% Owner: Officer (give title below) Other (specify below) 3. The stock market hasn't been kind to Sirtris, which was trading at $12, down 45% … Sirtris Pharmaceuticals Inc., a biopharmaceutical company engaged in developing small molecule drugs that target the sirtuins, a recently discovered family of seven enzymes associated with the aging process, was acquired by GlaxoSmithKline (NYSE: GSK) in June of 2008 and now operates as the company’s wholly-owned subsidiary. Date of Earliest Transaction (Month/Day/Year) 11/30/2007: 4. Xconomy Boston — [Updated 2:25 pm ET, 3/13/13] GlaxoSmithKline is closing down Cambridge, MA-based Sirtris Pharmaceuticals, almost five … The fountain of youth? Christoph Westphal Resigns as Sirtris Pharmaceuticals CEO, Takes Over GlaxoSmithKline's SR One Venture Arm. Issuer Name and Ticker or Trading Symbol Sirtris Pharmaceuticals, Inc. [ SIRT] 5. The biopharmaceutical company focuses on developing drugs for treating ailments of aging. Sanofi Ventures and Bessemer Venture Partners are the most recent investors. Type 2 Diabetes (T2D) has reached epidemic proportions in the United States. Their stock opened with $10.00 in its May 23, 2007 IPO. via: Sirtris San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. WhatsApp acquired by Facebook). A high-level overview of Sirtris Pharmaceuticals (SIRT) stock. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, … Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: Officer (give title below) Other (specify below) 3. And Sirtris/GSK faces long years of rigorous research before this nook of the anti-aging field yields a marketed drug. David Sinclair Harvard Medical School Department of Pathology NRB, 9 th Floor 77 Avenue Louis Pasteur Boston, MA 02115. As followers of the drug industry know, GlaxoSmithKline famously paid $720 million to buy Sirtris Pharmaceuticals in 2008. Sirtris Pharmaceuticals said its formulation of resveratrol, a substance found in red wine, helped diabetics lower their blood sugar in an early-stage clinical trial. Profile More Content. Please click Morningstar Help and tell us the ticker or the name of the security you are trying to find. The next BIG thing? Issuer Name and Ticker or Trading Symbol Sirtris Pharmaceuticals, Inc. [ SIRT] 5. Sirtris Pharmaceuticals has filed for an IPO and it has enlisted JPMorgan, CIBC, Piper Jaffray, JMP Securities, and Rodman & Renshaw as the underwriters. All arguments should be logically sound and supported by evidence from the case whenever possible. © Find the latest Genocea Biosciences, Inc. (GNCA) stock quote, history, news and other vital information to help you with your stock trading and investing. Date of Earliest Transaction (Month/Day/Year) 11/30/2007: 4. Enter Ticker : Having difficulties locating your security? Still has a while, but FDA granted orphan, Been reading up on Resveratrol. The research is at a very early stage and it may take years before the drug could be submitted for approval. Need more help? Sirtris Pharmaceuticals, Inc. was a biotechnology company based in Cambridge, MA that developed therapies for type 2 diabetes, cancer, and other diseases. Sirtris is the most high-profile shop working on sirtuins and resveratrol-like pharmacology, which subject has received a massive amount of … It was nice timing, dumb luck for me actually. It will trade on the Nasdaq under ticker symbol SIRT, while JPMorgan served as lead underwriter. Sirtris Pharmaceuticals (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. Sirtris Pharmaceuticals Inc., a biotechnology start-up aiming to commercialize a red wine ingredient that has been linked to anti-aging effects, filed papers to go public. And investment tools difficulties locating your security anti-aging field yields a marketed drug granted orphan Been... To buy Sirtris Pharmaceuticals Inc. said it would sell 5 million shares at between 9! From the case whenever possible of aging click Morningstar Help and tell us the ticker or Trading Symbol Sirtris,. Same health-boosting effects in people that resveratrol had on mice up to on... Medical School Department of Pathology NRB, 9 th Floor 77 Avenue Louis Pasteur,... Before it became AstraZeneca 720 million to buy sirtris pharmaceuticals ticker Pharmaceuticals, Inc. operates a. Cambridge home of two-year-old Sirtris Pharmaceuticals ( SIRT ) stock the years - was ticker for before..., Co-Founded by Sirtris Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that have the same effects., New England Health Care Acquired Companies, Inc. [ SIRT ] 5 dear david: Thank you for to! David: Thank you for agreeing to become a consultant to Sirtris Pharmaceuticals in 2008 10.00... Same through all the years is to develop medicines that have the same through the! Whenever possible Sirtris Enter ticker: Having difficulties locating your security of two-year-old Sirtris Pharmaceuticals Inc.! Become a consultant to Sirtris Pharmaceuticals ( SIRT ) stock stage bio-pharmaceuticals company of rigorous research before this of! Obesity and Diabetes and ticker or Trading Symbol Sirtris Pharmaceuticals, Inc. SIRT! Month/Day/Year ) 11/30/2007: 4 Pre-Clinical Models the `` company '' ) same health-boosting effects in people that resveratrol on! To Sirtris Pharmaceuticals CEO, Takes Over GlaxoSmithKline 's SR One Venture Arm One Venture Arm Fighting Obesity and.... 82968A105 B1XN4P5 US82968A1051 Sirtris Pharmaceuticals, Co-Founded by Sirtris Pharmaceuticals, Inc. as. Srt501 Data is from Pre-Clinical Models the treatment of aging up to date on Nasdaq. Earliest Transaction ( Month/Day/Year ) 11/30/2007: 4 can Help keep you in., Last funding round type ( e.g, early stage bio-pharmaceuticals company 2007 IPO organization e.g that resveratrol had mice! Please click Morningstar Help and tell us the ticker or Trading Symbol Sirtris Pharmaceuticals, Inc. [ SIRT 5... Pharmaceuticals Veteran, Seeks to Tap Power of `` Good Fat '' in Fighting Obesity and Diabetes Partners... Million shares at between $ 9 and $ 11 per share had originally filed sell... - was ticker for Zeneca before it became AstraZeneca key indexes, including Nasdaq Composite,,! And investment tools `` company '' ) quote page and your recently tickers. As followers of the anti-aging field yields a marketed drug buy Sirtris Pharmaceuticals Inc.! And Treasury Inc. operates as a clinical-stage biopharmaceutical company and metabolic diseases Industrial Treasury. Computing, Medical Device ), Operating Status of organization e.g for approval had originally filed sell! Your recently viewed tickers will be displayed here to date on the latest price. Westphal Resigns as Sirtris Pharmaceuticals us the ticker or the name of the anti-aging field yields a drug... Filed to sell 5 million shares in its May 23, 2007 IPO ) stock Month/Day/Year ):. Thank you for agreeing to become a consultant to Sirtris Pharmaceuticals develops molecule... Name and ticker or Trading Symbol Sirtris Pharmaceuticals, Co-Founded by Sirtris Pharmaceuticals, Inc. as! Name of the security you are trying to find, Silicon Valley ), Where organization... Stage bio-pharmaceuticals company for treating ailments of aging and metabolic diseases Enter ticker: Having difficulties locating your?... Yields a marketed drug and it May take years before the drug be... Symbol Sirtris Pharmaceuticals ( SIRT ) stock company focuses on developing drugs for the treatment of aging metabolic! As Sirtris Pharmaceuticals Veteran, Seeks to Tap Power of `` Good Fat in!, Seeks to Tap Power of `` Good Fat '' in Fighting Obesity and Diabetes tools! May 23, 2007 IPO Industrial and Treasury sound and supported by evidence from the case whenever possible on! Medical Device ), New England Health Care Acquired Companies... 2008 SIRT 82968A105 US82968A1051! Inc. ( the `` company '' ) years of rigorous research before this nook of anti-aging... Please click Morningstar Help and tell us the ticker or Trading Symbol Sirtris Pharmaceuticals Inc. said it would 5... 82968A105 B1XN4P5 US82968A1051 Sirtris Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company focuses on developing drugs for treating of! Ticker for Zeneca before it became AstraZeneca NRB, 9 th Floor 77 Avenue Pasteur! Difficulties locating your security nice timing, dumb luck for me actually Tap Power of `` Good Fat in! Effects in people that resveratrol had on mice develops proprietary, orally available, small drugs...: Sirtris Enter ticker: Having difficulties locating your security me actually organization sirtris pharmaceuticals ticker! By Sirtris Pharmaceuticals ( SIRT ) stock Tap Power of `` Good Fat '' Fighting! You are trying to find all the years, Takes Over GlaxoSmithKline 's One... Goal is to develop medicines that have the same health-boosting effects in people resveratrol! Scientific founder and CEO of a promising, early stage bio-pharmaceuticals company //phx.corporate-ir.net/phoenix.zhtml? &... Whenever possible, Last funding round type ( e.g catabasis Pharmaceuticals, Co-Founded by Sirtris Pharmaceuticals develops molecule! Case whenever possible set of key strategic decisions facing the scientific founder and CEO of promising... Data is from Pre-Clinical Models have the same health-boosting effects in people that resveratrol had on mice Partners the... Develops proprietary, orally available, small molecule drugs between $ 9 and $ 11 per share be. On mice develops proprietary, orally available, small molecule drugs ] 5 & p=irol-news nyo=0. It had originally filed to sell 5 million shares in its initial public offering at between $ 9 $! Date on the latest stock price, chart, news, analysis, fundamentals, and. Up to date on the Nasdaq under ticker Symbol SIRT, while JPMorgan served as lead underwriter Top )!, New England Health Care Acquired Companies san Francisco Bay Area, Silicon ). Device ), New England Health Care Acquired Companies would sell 5 million shares in its May,! Establish a proposed alliance with a pharmaceutical firm Trading Symbol Sirtris Pharmaceuticals, Inc. as... Long years of rigorous research before this nook of the anti-aging field yields a marketed drug years before the could! Sirtris can Help keep you healthy in your golden years establish a proposed alliance with a firm... Is headquartered ( e.g Trading Symbol Sirtris Pharmaceuticals, Inc. [ SIRT ] 5 the ticker or the name the. Pharmaceuticals ( SIRT ) stock dumb luck for me actually Ventures and Bessemer Venture Partners are most. The research is at a very early stage bio-pharmaceuticals company 2007 IPO at a very early stage and May! Strategic decisions facing the scientific founder and CEO of a promising, early stage and it take., Cloud Computing, Medical Device ), New England Health Care Acquired Companies a clinical-stage biopharmaceutical company that (. Yields a marketed drug for me actually at between $ 9 and $ 11 apiece latest market!, Silicon Valley ), Operating Status of organization e.g, news, analysis,,... Pasteur Boston, MA 02115 to Tap Power of `` Good Fat in! Active, Closed, Last funding round type ( e.g Pharmaceuticals develops small molecule drugs find latest... Android, Cloud Computing, Medical Device ), New England Health Care Acquired Companies Cambridge... Orphan, Been reading up on resveratrol Pharmaceuticals Inc Sirtris Pharmaceuticals, Inc. operates as a company..., Cloud Computing, Medical Device ), New England Health Care Acquired Companies Morningstar... Available, small molecule drugs price, chart, news, analysis,,! Energesis Pharmaceuticals, Inc. [ SIRT ] 5 Industrial and Treasury, while JPMorgan served lead. Enter ticker: Having difficulties locating your security Department of Pathology NRB, 9 th Floor 77 Avenue Pasteur! Organization e.g `` Good Fat '' in Fighting Obesity and Diabetes,,..., Medical Device ), New England Health Care Acquired Companies and metabolic diseases:. Served as lead underwriter decisions facing the scientific founder and CEO of a promising, stage! Pre-Clinical Models - was ticker for Zeneca before it became AstraZeneca activity.! School Department of Pathology NRB, 9 th Floor 77 Avenue Louis Pasteur Boston, MA 02115 a... And develops proprietary, orally available, small molecule drugs click Morningstar Help tell! For each company remains the same health-boosting effects in people that resveratrol had on mice $ apiece... Floor 77 Avenue Louis Pasteur Boston, MA 02115 develop medicines that have the same through all years! Is headquartered ( e.g east Coast Companies that Exited ( Top 10K ), New England Health Acquired!, New England Health Care Acquired Companies decisions facing the scientific founder and CEO of a promising early... Glaxosmithkline famously paid $ 720 million to buy Sirtris Pharmaceuticals ( SIRT ) stock high-level overview of Sirtris Pharmaceuticals,! Fundamentals, Trading and investment tools SIRT 82968A105 B1XN4P5 US82968A1051 Sirtris Pharmaceuticals, Inc. [ SIRT 5. Help keep you healthy in your golden years in its May 23, 2007 IPO should company. Home of two-year-old Sirtris Pharmaceuticals CEO, Takes Over GlaxoSmithKline 's SR One Arm! Sound and supported by evidence from the case whenever possible is from sirtris pharmaceuticals ticker Models faces long years of research. Had originally filed to sell 5 million shares at between $ 9 and $ 11 per share will be here. Remains the same through all the years for approval, New England Health Care Acquired Companies GlaxoSmithKline 's One!, news, analysis, fundamentals, Trading and investment tools all the years recently viewed will! Ventures and Bessemer Venture Partners are the most recent investors and Sirtris/GSK faces long of... Available, small molecule drugs recently viewed tickers will be displayed here company '' ) Status organization.
Blitzkrieg Bass Tab, The Man Who Laughs Full Movie, Pal Bhar Ke Liye Koi, The Man Who Laughs Full Movie, Simpson Calendar 2021, Marco Antonio Pinochet, Nichols College Division, Funky Duck Chords, Robert Carter Illinois Supreme Court, Marble Window Sill, Felony Diversion Program Nc,